doi.org/10.1016/s1470-2045(18)30062-7

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

Giuseppe Giaccone

,

,

The Lancet Oncology35.90

Volume: 19, Issue: 3, Pages: 347 - 355

Published: Jan 26, 2018

Paper Fields

Paper Details

Title

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

DOI

doi.org/10.1016/s1470-2045(18)30062-7

Published Date

Jan 26, 2018

Journal

The Lancet Oncology

Volume

19

Issue

3

Pages

347 - 355

Notes

History